0
Dicerna Pharmaceuticals Inc
- 11-50 Employees
- Based in Cambridge, Massachusetts
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding…More
Dicerna Pharmaceuticals Inc
Most Recent Responsibility Report
MOST RECENT
Shipping Information
Request Information
Dicerna Pharmaceuticals Inc does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived Dicerna Pharmaceuticals Inc Sustainability Report, Dicerna Pharmaceuticals Inc Corporate Social Responsibility Report, Dicerna Pharmaceuticals Inc CSR Report, Dicerna Pharmaceuticals Inc Corporate Responsibility, Dicerna Pharmaceuticals Inc CR Report, Dicerna Pharmaceuticals Inc Citizenship Report, Dicerna Pharmaceuticals Inc ESG Report, and Dicerna Pharmaceuticals Inc Environmental Report online.